Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heparin, antithrombin, and abnormal clotting.

× No keyword cloud information.

9 in total

Review 1. Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors: Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal: Adv Immunol Date: 2014 Impact factor: 3.543

2. Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum.

Authors: K T Preissner; L Zwicker; G Müller-Berghaus
Journal: Biochem J Date: 1987-04-01 Impact factor: 3.857

3. Rapid separation of bacteria from blood - Chemical aspects.

Authors: Mahsa Alizadeh; Ryan L Wood; Clara M Buchanan; Colin G Bledsoe; Madison E Wood; Daniel S McClellan; Rae Blanco; Tanner V Ravsten; Ghaleb A Husseini; Caroline L Hickey; Richard A Robison; William G Pitt
Journal: Colloids Surf B Biointerfaces Date: 2017-03-16 Impact factor: 5.268

4. Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units/day) in the treatment of patients with acute coronary event--first year and long-term comparative mortality.

Authors: J J Sayen; R B Singer; G Peirce; O Horwitz
Journal: Trans Am Clin Climatol Assoc Date: 1983

5. Evidence for antithrombin III involvement in the anticoagulant activity of cellulose sulphate.

Authors: G Kindness; W F Long; F B Williamson
Journal: Br J Pharmacol Date: 1980-04 Impact factor: 8.739

6. Heparin 1986. Indications and effective use.

Authors: P Ockelford
Journal: Drugs Date: 1986-01 Impact factor: 9.546

Review 7. Clinical pharmacokinetics of heparin.

Authors: J W Estes
Journal: Clin Pharmacokinet Date: 1980 May-Jun Impact factor: 6.447

8. Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel.

Authors: Dong-Hwan Kim; Ubonvan Termsarasab; Hyun-Jong Cho; In-Soo Yoon; Jae-Young Lee; Hyun Tae Moon; Dae-Duk Kim
Journal: Int J Nanomedicine Date: 2014-12-08

Review 9. Heparin: role in protein purification and substitution with animal-component free material.

Authors: Svenja Nicolin Bolten; Ursula Rinas; Thomas Scheper
Journal: Appl Microbiol Biotechnol Date: 2018-08-09 Impact factor: 4.813

9 in total